跳至主要内容
临床试验/ITMCTR2200005592
ITMCTR2200005592尚未招募未知

Effectiveness and safety of Yizhiqingxin Formula in treating patients with vascular dementia(stasis toxin syndrome)

Xiyuan Hospital,China Academy of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
45 至 75(—)
性别
All

入选标准

  • Diagnostic criteria:
  • ? American Psychiatric Association Diagnostic Manual and Statistical Manual of Mental Disorders Standard (DSM-IV);
  • ?2002 Chinese Medical Association Neurology Branch Draft Diagnostic Criteria for Vascular Dementia.
  • ?Age =45 years old and =75 years old, both male and female; women should be postmenopausal women who are infertile.
  • ?Meet the above diagnostic criteria for dementia, VD diagnostic criteria and TCM syndrome diagnostic criteria, and the course of dementia is more than 3 months.
  • ? The degree of CDR dementia was assessed as mild and moderate dementia (CDR=1.0, 2.0).
  • ? Mini-Mental State Examination Scale (MMSE) = 26 points, = 10 points.
  • ?HIS points = 7 points.
  • ? Volunteers and signed informed consent.
  • ? Have a correct understanding of the significance of drug research, and have good compliance with the observation and evaluation of researchers.
  • ? Have a certain degree of education, can read simple newspaper articles and write simple small articles in the past.

排除标准

  • ? Alzheimer's disease patients with HIS score =4 points and mixed dementia patients with 5-6 points.
  • ? Patients with dementia and depression were excluded.
  • ? Patients with CDR=3.0.
  • ? Dementia patients after cerebral hemorrhage or large cortical infarction.
  • ? Those with severe neurological deficits.
  • ? Patients with severe heart, liver and kidney function.
  • ? Patients who have used any history of drugs that may affect cognitive function in the past 3 months.

研究者

发起方
Xiyuan Hospital,China Academy of Traditional Chinese Medicine

相似试验